C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids

More topics under "C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids" (173,078)
C07H 1 - Processes for the preparation of sugar derivatives (12,374)
C07H 11 - Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof (1,722)
C07H 13 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids (4,753)
C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
C07H 23 - Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin b12 (1,716)
C07H 3 - Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms (5,762)
C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium (3,671)
C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294)
C07H 9 - Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical (1,178)
C07H 99 - Subject matter not provided for in other groups of this subclass (52)

Patents for C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids (1,168)
08/1996
08/20/1996	US5547667 Linker for bioactive agents
07/1996
07/30/1996	US5541345 Anomeric fluororibosyl amines
07/24/1996	CN1127116A New composition and subcompositions of same: process for obtaining them and their molecular identification, and their anti-inflammatory, analgesic, antipruritic and local antipyretic therapeutic effec
06/1996
06/25/1996	US5529919 Method of making endoglucanase I
05/1996
05/29/1996	CN1031879C Process for preparing ATP analogues
05/29/1996	CN1031878C Process for preparing mono and bis alkylamino anthracyclines
05/22/1996	EP0712273A1 Hmg2 promoter expression system and post-harvest production of gene products in plants and plant cell cultures
05/17/1996	WO1996014326A1 Antifungal sordaridin derivatives
05/17/1996	CA2179403A1 Antifungal sordaridin derivatives
05/15/1996	EP0711771A2 Substituted-1,3-oxathiolanes with antiviral properties
04/1996
04/24/1996	CN1120936A Process for the production of a pharmaceutical composition comprising an ATP anologue
04/17/1996	EP0706797A2 Compositions containing carbohydrates obtained from plants of the family cactacea
03/1996
03/27/1996	EP0495053B1 New linker for bioactive agents
03/05/1996	US5496808 Mono and bis alkylamino-anthracyclines
02/1996
02/22/1996	WO1996000068A3 Combination therapy for hiv infection
02/17/1996	CA2156197A1 Composition and subcompositions of same: process for obtaining them and their molecular identification, and their anti-inflammatory, analgesic, antipruritic and local antipyretic therapeutic effect in human beings and animals
02/01/1996	WO1996002252A1 USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA
02/01/1996	CA2195345A1 Use of (s)-adenosyl-l-methionine (same) and its physiologically compatible salts for treating reperfusion damage triggered by temporary focal ischaemia
01/1996
01/30/1996	US5487984 Processes for producing tumor necrosis factor
01/18/1996	DE4425280A1 Verwendung von (S)-Adenosyl-L-methionin (SAMe) und dessen physiologisch verträglichen Salzen zur Behandlung von Reperfusionsschäden, die durch temporäre fokale Ischämie ausgelöst werden Use of (S) -Adenosyl-L-methionine (SAMe) and its physiologically acceptable salts for treating reperfusion damage triggered by temporary focal ischemia
01/10/1996	EP0691344A1 Purification of trehalose
01/04/1996	WO1996000068A2 Combination therapy for hiv infection
01/04/1996	CA2193221A1 Combination therapy for hiv infection
01/03/1996	EP0689405A1 Methods for protecting tissues and organs from ischemic damage
01/02/1996	US5480992 Anomeric fluororibosyl amines
12/1995
12/20/1995	EP0541722B1 Compounds and methods for inhibiting gene expression
12/19/1995	CA2078630C Denture cleansing device
11/1995
11/30/1995	WO1995032306A1 Method for detecting a target nucleic acid
11/22/1995	CN1112119A 13-substituted milbemycin derivatives, their preparation and use
11/07/1995	US5464826 Antitumor, anticarcinogenic agents, treatment of herpes
11/02/1995	EP0679160A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
10/1995
10/18/1995	CN1110280A Targeted forms of methyltrithio antitumor agents
10/11/1995	CN1109755A Antiviral, Highly water soluble, stable, crystalline salts of 2',3'-dideoxyinosine monohydrate 2',3',-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate
10/04/1995	EP0675133A1 13-Substituted milbemycin derivatives, their preparation and use
10/03/1995	US5455168 α-glycosyl trehalose-forming enzyme
08/1995
08/22/1995	US5444051 Erythromycin compounds
08/22/1995	US5443836 Methods for protecting tissues and organs from ischemic damage
07/1995
07/11/1995	US5432164 C2,N6 -disubstituted adenosine derivatives
05/1995
05/31/1995	EP0654998A1 METHOD OF NEUTRALIZING IL-1 USING dsRNAs
04/1995
04/26/1995	EP0649854A1 Bisconjugates comprising two saccharides and a spacer
04/12/1995	EP0647654A2 Anomeric flouroribosyl amines
04/12/1995	EP0214971B1 Yeast strains producing cellulolytic enzymes and methods and means for constructing them
03/1995
03/29/1995	CN1100728A Nucleosides and oligonucleotides having 2'-ether groups
03/15/1995	CN1027896C Antiviral, highly water soluble, stable, crystalline salts of 2'-3'-dideoxyinosine monohydrate, 2'3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-Fluoroinosine hemihydrate
02/1995
02/28/1995	US5393670 DNA, vectors and transformed hosts encoding Trichoderma reesei endoglucanase I
02/09/1995	CA2168430A1 Hmg2 promoter expression system and post-harvest production of gene products in plants and plant cell cultures
02/07/1995	US5387578 Releasing drugs from bioactive agents in order to improve the therapeutic efficacy and reduce their toxic effects
01/1995
01/31/1995	CA1334166C Antiviral preparation containing dideoxy-nucleosides
01/04/1995	CN1027267C Method for preparing of N-acyl derivatives of LL-E33288 antitumor antibiotics
12/1994
12/28/1994	EP0548189B1 A method of linking nucleosides with a siloxane bridge
12/28/1994	CN1027169C Method for preparation of epiodophylltoxin glucoside 4'-phosphate
11/1994
11/30/1994	EP0626387A1 Nucleosides and oligonucleotides with 2'-ether groups
11/30/1994	EP0427799B1 Method and compounds for aica riboside delivery and for lowering blood glucose
11/23/1994	CN1095268A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
09/1994
09/29/1994	WO1994021195A1 Methods for protecting tissues and organs from ischemic damage
09/20/1994	US5348946 Heteroanthracycline antitumor analogs
08/1994
08/31/1994	CN1091470A Unreductases produced of saccharide preparation and application of same
08/10/1994	EP0609375A1 Novel 2,6-disubstituted purine derivatives
07/1994
07/20/1994	EP0606753A2 Non-reducing saccharide-forming enzyme, and its preparation and uses
07/07/1994	WO1994014456A1 Use of dideoxy nucleoside analogues in the treatment of viral infections
07/06/1994	EP0205475B1 Recombinant methods for production of serine protease inhibitors and dna sequences useful for same
06/1994
06/23/1994	WO1994013687A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
06/09/1994	WO1994012188A1 Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections
05/1994
05/25/1994	EP0597915A1 A process for making morphine-6-glucuronide or substituted morphine-6-glucuronide
05/18/1994	EP0596912A1 Modulation and diagnosis of cytokine dysfunctions
05/04/1994	EP0594624A1 Dynemicin analogs: syntheses, methods of preparation and use
04/1994
04/26/1994	US5306492 Oligosaccharide conjugated to carrier protein
03/1994
03/16/1994	EP0587298A2 Nucleic acid sequence amplification method
02/1994
02/21/1994	EP0594624A4 Dynemicin analogs: syntheses, methods of preparation and use.
02/17/1994	WO1994003472A1 Nucleic acid sequence amplification
02/09/1994	EP0581906A1 ABROGATION OF VIRAL RESISTANCE TO NUCLEOSIDE ANALOGUES BY DOUBLE-STRANDED RNAs
01/1994
01/26/1994	EP0579643A1 Atp analogues
01/05/1994	CN1080292A Antivibal compounds
01/04/1994	US5275185 Dentures cleansing device
08/1993
08/11/1993	EP0218651B1 A dna sequence
07/1993
07/21/1993	EP0242359B1 A cloning vehicle for cloning a large fragment of dna and a vaccine comprising 987p fimbrial protein
07/21/1993	EP0179887B1 Adhesin antigens, antibodies and dna fragment encoding the antigen, methods and means for diagnosis and immunization etc.
07/20/1993	CA1320464C Antibiotic a80190
06/1993
06/23/1993	EP0547910A1 A process for preparing 2-chloro-2'-deoxyadenosine
06/15/1993	CA1319143C Antiviral compounds
05/1993
05/26/1993	EP0462100B1 Method for purifying nucleic acids
05/25/1993	US5214134 Antisense agents, inhibition of gene expression
05/25/1993	CA1318317C Preparation of a new diosmine derivative
05/19/1993	EP0541722A1 Compounds and methods for inhibiting gene expression.
05/05/1993	EP0539380A1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
05/04/1993	US5208327 Intermediates useful in a synthesis of 2-chloro-2'-deoxyadenosine
04/1993
04/29/1993	WO1993008206A1 Novel 2,6-disubstituted purine derivatives
04/29/1993	CA2121844A1 Novel 2,6-disubstituted purine derivatives
04/28/1993	CN1071433A Digestive tract contractile motion stimulant
04/07/1993	EP0535351A1 Cleaning device for dental prosthesis
04/07/1993	EP0535200A1 Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use
04/01/1993	WO1993005788A1 METHOD OF NEUTRALIZING IL-1 USING dsRNAs
04/01/1993	CA2120027A1 Method of neutralizing il-1 using dsrnas
03/1993
03/31/1993	EP0295248B1 Liposome preparation and antibiotic
03/31/1993	CN1020194C Method for preparation of difluorated nucleoside derivant
03/23/1993	CA1314876C Azithromycin dihydrate
03/17/1993	CN1069981A Mono and bis alkylamino-anthracyclines
03/16/1993	CA1314481C Liposomal preparation and antibiotic
03/03/1993	EP0529715A1 Sulfated glycosaminoglycanoid derivatives
02/1993
02/18/1993	WO1993003051A1 A process for making morphine-6-glucuronide or substituted morphine-6-glucuronide

1 2 3 4 5 6 7 8 9 10 11 12